1 result(s) for
|PI Name||Protocol #||Title|
|Shivaani Kummar||STUDY00021766||A Phase I/Ib Study to Evaluate the Safety, Tolerability, Biological and Clinical Activities of GEN-001 in Combination with Avelumab in Patients with Advanced Solid Tumors Who Have Progressed during or after Treatment with Anti-PD-(L)1 therapy|
You may also qualify for Phase 1 Program trials.
For more information: